Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of CTDNA Response Adaptive Immuno-Chemotherapy in Lung Cancer	Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm	Active, not recruiting	Phase 2 / Phase 3	2026-07-31		NCT04093167

4 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Canadian Cancer Trials Group	73
Cancer Research Institute, New York City	3
Mark Foundation for Cancer Research	1
Personal Genome Diagnostics	3

11 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Algoma District Cancer Program	Sault Ste. Marie	Canada	6
BCCA - Vancouver	Vancouver	Canada	22
Cross Cancer Institute	Edmonton	Canada	146
Health Sciences North	Greater Sudbury	Canada	25
Juravinski Cancer Centre at Hamilton Health Sciences	Hamilton	Canada	60
Kingston Health Sciences Centre	Kingston	Canada	91
Ottawa Hospital Research Institute	Ottawa	Canada	46
The Jewish General Hospital	Montreal	Canada	20
The Sidney Kimmel Comprehensive Cancer Centre	Baltimore	United States	1
The University of Chicago Medical Center	Chicago	United States	33
University Health Network	Toronto	Canada	52